Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Pinnacle Biologics Acquires PDT Laser Tech
Dec 2012
BANNOCKBURN, Ill., Dec. 5, 2012 — Pinnacle Biologics Inc. has completed its portfolio of photodynamic therapy (PDT) treatment components with the acquisition of Diomed’s PDT 630 laser and fiber optic diffuser Optiguide. Financial terms were not disclosed.

The privately-held biopharmaceutical company’s acquisitions are the only FDA-approved devices for use in PDT with Photofrin (porfimer sodium) for injection.

Photofrin — acquired by the company in March 2011 — is a two-stage process requiring administration of both drug and light. When injected, it is attracted to certain tissues, especially cancer cells, and is FDA-approved for the treatment of nonsmall-cell lung and esophageal cancer.

For more information, visit:

The technology of generating and harnessing light and other forms of radiant energy whose quantum unit is the photon. The science includes light emission, transmission, deflection, amplification and detection by optical components and instruments, lasers and other light sources, fiber optics, electro-optical instrumentation, related hardware and electronics, and sophisticated systems. The range of applications of photonics extends from energy generation to detection to communications and...
AmericasBiophotonicsBusinessDiomed PDT 630 laseresophageal cancerFDAIllinoislaserslight therapylung cancerOptiguide fiber optic diffusersPDTphotodynamic therapyPhotofrinphotonicsPinnacle Biologicsporfimer sodium

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.